Predictors of one-year adverse outcomes after laparoscopic resection for hepatocellular carcinoma: Development and validation of an early-warning model

Table 2 Baseline data comparison (good vs poor prognosis groups in the training group)

Variable	Poor prognosis group (n = 67)	Good prognosis group (n = 210)	Statistical values	P value
Sex
Male	46	136	0.342	0.559
Female	21	74
History of smoking
Yes	30	106	0.660	0.416
No	37	104
History of alcohol consumption
Yes	32	98	0.024	0.876
No	35	112
History of hypertension
Yes	21	68	0.025	0.874
No	46	142
History of diabetes
Yes	10	23	0.764	0.382
No	57	187
Hepatitis B
Yes	46	147	0.043	0.835
No	21	63
Child-Pugh classification
A	41	129	0.001	0.973
B	26	81
Tumor diameter
≥ 5 cm	37	83	5.099	0.024
< 5 cm	30	127
Tumor number
Single	48	173	3.632	0.057
Multiple	19	37
Degree of differentiation
Poorly differentiated	13	23	3.208	0.073
Moderately or well differentiated	54	187
Vascular invasion
Yes	23	43	5.370	0.020
No	44	167
Hepatic vein infiltration
Yes	6	12	0.878	0.349
No	61	198
Portal vein infiltration
Yes	15	22	6.228	0.013
No	52	188
Cirrhosis
Yes	47	118	4.109	0.043
No	20	92
AFP
≥ 400 μg/L	33	42	22.015	< 0.001
< 400 μg/L	34	168
WBC (× 109/L)	6.96 ± 1.25	6.51 ± 1.27	2.583	0.011
PLT (× 109/L)	141.88 ± 25.84	136.32 ± 24.27	1.555	0.123
ALB (g/L)	38.28 ± 8.21	39.27 ± 7.48	-0.886	0.378
ALT (U/L)	96.51 ± 17.76	94.83 ± 17.27	0.679	0.499
AST (U/L)	100.42 ± 18.82	101.01 ± 17.87	-0.224	0.823
TBIL (μmol/L)	19.39 ± 3.73	19.22 ± 3.61	0.33	0.742

AFP: Alpha-fetoprotein; WBC: White blood cell count; PLT: Platelet count; ALB: Albumin; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; TBIL: Total bilirubin.